Are you front of mind when biopharma companies look externally for assistance
in the development of bispecifics?
Bispecific approaches continue to emerge as important and commercially valuable therapeutic options, a trend that has been demonstrated clearly by the recent investments in this space by companies like Sanofi, Seattle Genetics and Janssen.
The 9th Annual World Bispecific Summit will bring together key decision-makers from these companies, as well as host of other industry-leading pharma and biotech organizations, who are actively seeking collaborators to overcome challenges in developing the next generation of bispecific therapeutics.
This uniquely focused gathering will provide you with a unique opportunity to showcase your expertise and solutions in front of an engaged audience of pharma and biotech companies committed to realizing the potential of bispecifics.
Act now to stay ahead of the curve and seize the wealth of opportunity on offer.
Get in touch today for more information about the various partnership opportunities available.
We’d love to here from you. Email us today at firstname.lastname@example.org and we can discuss your options further.
“I got a great overview of bispecifics and what they are utilized for. I talked to companies that want to use our instrument for transient material. It was a great conference for me.”
“This meeting gave me clear ideas for how we can take our platform to the next level”